Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clones from Paraguayan children.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 03 2020
Historique:
received: 14 10 2019
accepted: 24 02 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 5 1 2021
Statut: epublish

Résumé

Staphylococcus aureus is considered one of the most important human pathogens, and its levels of resistance to methicillin have increased even in strains isolated from people without nosocomial risk factors. Molecular analysis is essential for understanding the patterns of dissemination. The objective of this study was to identify community-acquired methicillin-resistant S. aureus (CA-MRSA) clones that infected Paraguayan children patients in two periods of time. An observational, descriptive study was designed to determine the genetic variability of 115 isolates of CA-MRSA recovered from children who attended four reference centers in Paraguay between 2009-2010 and 2012-2013. The combined use of Pulsed Field Gel Electrophoresis (PFGE), Multi-Locus Sequencing Typing, Multi-Locus Variable Analysis (MLVA) and Spa typing techniques allowed the identification of two dominant clones: ST30-IV-t019 (77%) and ST5-IV-t311 (10%), and the establishment of the former as the leading cause of CA-MRSA infections in children during the study period. This is the first study that provides epidemiological information as well as microbiological and molecular characteristics of CA-MRSA isolates recovered from children from Asunción and the Central Department of Paraguay.

Identifiants

pubmed: 32235090
doi: 10.3855/jidc.12108
doi:

Substances chimiques

Anti-Bacterial Agents 0
Virulence Factors 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

290-297

Informations de copyright

Copyright (c) 2020 Fatima Rodriguez, Claudia Salinas, Silvina Fernandez, Sol Haim, Marta Mollerach, Wilma Basualdo, Hector Castro, Beatriz Quinonez, Rocio Arguello, Monica Rodriguez, Lorena Grau, Carmen Espínola, Gladys Velazquez, Gloria Samudio, Gloria Gomez, Ana Campuzano, Juana Ortellado, Patricia Almada, Rosa Guillen.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Fátima Rodriguez (F)

Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción. San Lorenzo, Paraguay. farrodriguez288@gmail.com.

Claudia Salinas (C)

Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción. San Lorenzo, Paraguay. salinasdavalos@gmail.com.

Silvina Fernandez (S)

Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. silvinafernandez23@gmail.com.

Sol Haim (S)

Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. solhaim@gmail.com.

Marta Mollerach (M)

Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. martamollerach@gmail.com.

Wilma Basualdo (W)

Hospital General Pediátrico Niños de Acosta Ñú, Ministerio de Salud Pública y Bienestar Social, San Lorenzo, Paraguay.

Hector Castro (H)

Hospital General Pediátrico Niños de Acosta Ñú, Ministerio de Salud Pública y Bienestar Social, San Lorenzo, Paraguay. castrohec@gmail.com.

Beatriz Quiñónez (B)

Hospital General Pediátrico Niños de Acosta Ñú, Ministerio de Salud Pública y Bienestar Social, San Lorenzo, Paraguay.

Rocio Arguello (R)

Hospital General Pediátrico Niños de Acosta Ñú, Ministerio de Salud Pública y Bienestar Social, San Lorenzo, Paraguay. rochiarguello@yahoo.com.ar.

Monica Rodriguez (M)

Instituto de Previsión Social. Asunción, Paraguay. morodrig@ips.gov.py.

Lorena Grau (L)

Instituto de Previsión Social. Asunción, Paraguay. lorenagrau@gmail.com.

Carmen Espínola (C)

Instituto de Previsión Social. Asunción, Paraguay. mcespino@ips.gov.py.

Gladys Velázquez (G)

Instituto de Previsión Social. Asunción, Paraguay. g-velazquez@hotmail.com.

Gloria Samudio (G)

Hospital Nacional de Itauguá, Ministerio de Salud Pública y Bienestar Social. Itauguá, Paraguay. gsamudio.samudio@gmail.com.

Gloria Gomez (G)

Hospital Nacional de Itauguá, Ministerio de Salud Pública y Bienestar Social. Itauguá, Paraguay. gloryegom@yahoo.com.mx.

Ana Campuzano (A)

Hospital de Clínicas, Facultad de Ciencias Médicas. Universidad Nacional de Asunción San Lorenzo, Paraguay. campuzanorolon@gmail.com.

Juana Ortellado (J)

Hospital de Clínicas, Facultad de Ciencias Médicas. Universidad Nacional de Asunción San Lorenzo, Paraguay. juaniorte@yahoo.com.mx.

Patricia Almada (P)

Hospital de Clínicas, Facultad de Ciencias Médicas. Universidad Nacional de Asunción San Lorenzo, Paraguay. pattyal76@yahoo.com.ar.

Rosa Guillén (R)

Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción. San Lorenzo, Paraguay. rmguillenf@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH